Yield10 bioscience, inc. (YTEN)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue:
Revenue

861

806

801

653

620

556

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue from termination of ADM collaboration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38,885

0

0

0

-

-

-

-

-

-

Product revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

418

516

546

-762

-838

-227

461

1,470

1,501

1,052

276

0

0

0

-

-

-

-

-

-

Grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

1,326

1,159

919

773

1,055

1,350

1,755

1,818

1,811

1,807

1,910

2,083

2,204

2,480

2,427

2,440

2,317

1,971

1,766

1,633

1,271

918

588

150

0

0

0

License fee and royalty revenue from related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

444

460

0

0

0

Research and development revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

618

0

0

0

-

-

-

-

-

-

-

-

-

0

License fee and royalty revenue (Note 12)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

641

505

447

296

196

233

219

225

226

253

249

0

0

0

-

-

-

-

-

-

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

1,326

1,159

452

306

862

1,350

2,572

2,877

2,832

2,800

1,444

1,441

2,448

3,778

4,740

4,785

4,002

41,381

41,358

41,153

40,421

1,425

1,032

672

0

0

0

Expenses:
Cost of product revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,070

1,400

1,482

1,397

741

1,517

1,908

2,105

2,291

1,532

1,030

0

0

0

-

-

-

-

-

-

Research and development

5,085

4,848

4,733

4,836

4,905

4,783

4,914

4,711

4,589

4,597

4,527

4,942

5,351

5,670

1,216

1,333

4,105

6,602

13,970

16,394

16,455

17,342

17,763

18,190

18,755

18,802

21,514

21,930

21,991

23,177

22,075

23,297

24,291

24,445

24,258

23,943

0

0

0

General and administrative

4,755

4,554

4,144

4,571

5,002

5,092

5,564

5,220

5,630

5,630

5,001

5,458

4,741

5,737

5,469

5,708

7,023

7,217

9,235

9,938

10,139

10,805

10,670

10,671

11,428

11,608

11,446

12,143

12,158

13,245

14,969

15,694

16,453

15,841

16,039

15,992

0

0

0

Total expenses

9,840

9,402

8,877

9,407

9,907

9,875

10,478

9,931

10,219

10,227

9,528

10,400

10,092

11,407

6,511

6,867

11,044

13,819

23,489

27,402

27,994

29,629

29,830

29,602

31,700

32,318

35,065

36,364

35,681

37,452

37,852

39,483

40,799

40,286

40,297

39,935

0

0

0

Loss from operations

-8,979

-8,596

-8,076

-8,754

-9,287

-9,319

-9,953

-9,259

-9,539

-9,283

-8,347

-8,969

-8,766

-10,248

-6,059

-6,561

-10,182

-12,469

-20,917

-24,525

-25,162

-26,829

-28,386

-28,161

-29,252

-28,540

-30,325

-31,579

-31,679

3,929

3,506

1,670

-378

-38,861

-39,265

-39,263

0

0

0

Interest income, net

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense, net

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense):
Fair Value Adjustment of Warrants

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

7

3

7

31

31

46

51

72

95

117

124

172

164

153

156

92

107

0

0

0

Other income (expense), net

19

21

-84

-62

-51

-24

78

-3

-57

-113

0

0

0

-

-

-

-

29

85

87

39

54

-23

-38

-66

-55

-51

-63

0

-

0

0

-

-

-

-

-

-

-

Total other income (expense)

0

-

-

-

0

-

-

-

-

-

-

-

-

-

0

0

0

-

89

94

42

61

8

-7

-20

-4

2

20

0

-

0

0

-

-

-

-

-

-

-

Net loss from operations before income tax expense

0

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax expense

0

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-9,189

-10,722

0

0

-

0

-

-

-26,768

-27,459

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Income from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

2,682

461

0

0

-

0

-

-

-1,878

-2,183

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Income tax provision

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from write down of assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total net income from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

1,585

-798

0

0

-

0

-

-

-2,766

-3,074

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Available to Common Stockholders, Basic

-

-

-7,960

-8,616

-

-

-11,302

-10,689

-11,023

-10,823

-8,776

-2,727

-3,198

-7,604

0

0

0

-

0

0

0

-

0

0

0

-

-31,397

-31,891

-31,973

3,630

3,544

1,729

-305

-38,785

-39,173

0

0

0

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net loss per share (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.23

-0.20

-0.27

-0.23

-0.23

0.84

-0.27

-0.28

-0.33

-0.36

-

-0.36

Net loss from continuing operations (in USD per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.56

-0.90

-0.13

-

-0.12

-

-

-

-0.71

-1.16

-0.21

-

-0.19

-

-

-

-

-

-

-

-

-

-

-

-

Net loss from discontinued operations (in USD per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2.00

-0.25

-0.11

-

-0.10

-

-

-

-0.13

-0.08

-0.02

-

-0.02

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net loss per share (in USD per share)

-2.12

-26.58

-0.16

-0.15

-8.61

-36.25

-0.26

-0.24

-0.24

-1.00

-0.59

-0.96

-0.74

-

1.44

-1.15

-0.24

-

-0.22

-0.26

-0.26

-

-0.84

-1.24

-0.23

-

-0.21

-

-

-

-

-

-

-

-

-

-

-0.37

-

Net income (loss) per share, Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.23

-0.20

-0.27

-0.23

-0.23

0.84

-0.27

-0.28

-0.33

-0.36

-

-0.36

Number of shares used in per share calculations:
Basic and diluted (in shares)

1,697

-23,815

12,518

12,494

262

-28,707

10,010

9,991

9,698

4,054

3,410

2,849

2,839

-21,801

2,786

2,771

27,367

27,375

26,979

23,117

22,556

-9,049

9,381

5,831

34,806

-

34,516

-

-

-

-

-

-

-

-

-

-

-

-

Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34,434

34,353

34,305

34,243

34,183

34,136

34,220

34,080

29,824

26,904

26,880

26,780

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34,434

34,353

34,425

34,243

34,183

34,265

34,220

34,080

29,824

26,904

26,880

26,780

Grant
Revenue

861

806

801

653

620

556

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-